Navigation Links
Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
Date:1/29/2010

CHARLOTTESVILLE, Va., Jan. 29 /PRNewswire/ -- Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat serious or life-threatening unmet medical conditions, today announced that it closed on $5.9 million in additional private financing during the second half of 2009, bringing the total the company raised in 2009 to $7.1 million. The financing was a combination of private equity and convertible notes to existing investors.  Proceeds will support the company's ongoing operations, including completion of a Phase I/II clinical trial in peripheral arterial disease (PAD) patients for its lead drug compound, trans sodium crocetinate (TSC).

"The successful financing in 2009 gives us the ability to complete our ongoing clinical trial in PAD and position the company for critical post proof-of-concept activities," said David G. Kalergis, Chief Executive Officer.

Since its founding, Diffusion Pharmaceuticals has raised a total of $21.7 million to date including $19.1 million in private funds, and $2.6 million in Department of Defense research and development contracts.

About Diffusion Pharmaceuticals LLC

Diffusion Pharmaceuticals LLC is a clinical-stage drug-development company commercializing a family of first-in-class drug candidates to treat serious or life-threatening medical conditions. These proprietary small molecules use a novel method of action to enhance oxygen diffusion to oxygen-deprived (hypoxic) tissue. Potential clinical applications include cancer, critical care uses such as trauma, hemorrhage, stroke, and heart attack, as well as chronic conditio
'/>"/>

SOURCE Diffusion Pharmaceuticals LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
2. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
3. Intercept Pharmaceuticals Raises $25 Million Series B Financing
4. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
5. Amylin Pharmaceuticals to Webcast Year-End Financial Results
6. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
7. Sagent Pharmaceuticals Launches Pamidronate Disodium Injection
8. Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
9. Barclays Wealth Recommends Increasing Exposure to Laggard Sectors Including Consumer Staples, Pharmaceuticals and Telecoms
10. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
11. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the Bank of America Merrill Lynch 2015 ... a.m. Pacific time from the Encore at the Wynn in ... the presentation can be accessed at www.meipharma.com . A ...
(Date:5/6/2015)... , May 6, 2015  TriStar Wellness Solutions(R), ... that targets opportunities in the advanced wound care ... Oregon based wholly owned independent subsidiary ... funding from the National Institutes of Health (NIH) ... that is able to be delivered by a ...
(Date:5/6/2015)... , May 6, 2015  Genomic Health, Inc. (Nasdaq: ... , Chairman of the Board, Chief Executive Officer & ... Lynch 2015 Healthcare Conference in Las Vegas ... Pacific Time (PT). To access the live ... the  Investor Relations  section of the company,s web site ...
Breaking Medicine Technology:MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 3Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 4Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 5Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 2Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 3
... , , ROSH ... of innovative solutions for the advanced chronic,wound management market, ... Food and Drug Administration (FDA) to market its new,SilverStream(TM) ... Over-the-Counter version of the SilverStream product. , ...
... , , , , ... NXTM ), a leading manufacturer of innovative dialysis products, ... and their partners will be embarking on a week-long, conventional ... The cruise, dubbed the "2010 Freedom Cruise: We,re Taking Home ...
Cached Medicine Technology:EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4
(Date:5/6/2015)... Topical BioMedics, Inc., announces its May Pain Management Webinar will ... streamed live and then archived and accessible on demand 24/7. ... clicking on the following link: http://bit.ly/PMW_FIBRO . ... the webinar, and questions may also be submitted in advance ... the May webinar is “What You need to Know about ...
(Date:5/6/2015)... Cloud security companies Sookasa Inc ... partnership to help small-to-medium businesses secure their sensitive data ... are teaming up to transition SafeMonk customers to Sookasa’s ... to welcome SafeMonk users to the Sookasa family, and ... SafeMonk, the global powerhouse SafeNet (now Gemalto IDSS), are ...
(Date:5/6/2015)... Arizona (PRWEB) May 06, 2015 ... IMMEDIATE RELEASE , Med Ag Ventures, Inc. (MAV), ... manufacturing capacity of its Arizona based Phoenician Engineering ... grinders last September. MAV recently achieved profitability from ... network expanded from 100 at the end of ...
(Date:5/6/2015)... Hope For The Warriors® and American ... at the New York Athletic Club on April 21, ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... local and nationwide military families. The Barry Fixler Foundation/Semper ...
(Date:5/6/2015)... 06, 2015 The Jefferson Awards ... to activating and celebrating public service, announced today ... Health, as an Outstanding Employee Volunteer Organization. Champions ... Awards Foundation, are dedicated to building a culture ... decade, Highmark Health has recognized employees who volunteer ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:4th Annual Casino Night Draws Support for Military Families in New York City Region 2Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4
... rapidly changing the clinical practice of oncology. As scientists ... development of new tools capable of multiple, inexpensive biomarker ... essential to the success of genetically informed and personalized ... now developed a microfluidic image cytometry (MIC) platform that ...
... a single rock being overturned or an entire mountaintop ... processes, and vice versa. Ecological scientists will discuss findings ... growth to the diversity of insect species on green ... buildingsat the Ecological Society of America,s 95th Annual Meeting ...
... , , , , , ... , , AUDIO: ... School of Medicine... , Click here for more information. ... , , , , , ...
... HealthDay Reporter , MONDAY, August 2 (HealthDay News) -- ... than normal are at greater risk of developing artery-clogging ... of the arteries leading to heart disease, a new ... common assumption that modestly high cholesterol levels are nothing ...
... August 2, 2010 From the many images sent home ... viewed the plight of their country,s combat-weary veterans as stark ... But recent research at Washington State University (WSU) suggests that, ... often sets the trajectory of the balance of their lives. ...
... PICK: Boosting the efficacy of anticancer vaccines ... anticancer vaccines, which are designed to boost the patient,s ... example, the viruses used to deliver the tumor protein ... the patient,s immune system, inducing neutralizing and suppressive responses. ...
Cached Medicine News:Health News:New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors 2Health News:New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors 3Health News:Scientists unravel human-ecosystem interactions 2Health News:Scientists unravel human-ecosystem interactions 3Health News:Scientists unravel human-ecosystem interactions 4Health News:Colitis patients diagnosed later in life tend to have better disease outcomes 2Health News:Colitis patients diagnosed later in life tend to have better disease outcomes 3Health News:Colitis patients diagnosed later in life tend to have better disease outcomes 4Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 2Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 3Health News:High Cholesterol in Youth Boosts Heart Risk In Middle Age 4Health News:Sociologist finds combat veterans face more lifelong socioeconomic challenges 2Health News:JCI online early table of contents: August 2, 2010 2Health News:JCI online early table of contents: August 2, 2010 3Health News:JCI online early table of contents: August 2, 2010 4Health News:JCI online early table of contents: August 2, 2010 5Health News:JCI online early table of contents: August 2, 2010 6
... refrigerator is specially designed ... blood in standard 500ml ... Standard AS3864 1997. Quiet ... utilising CFC Free refrigerant ...
TBR-720-2-GD is large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standard AS38...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... circulating testosterone exists as unbound or free ... to SHBG with high affinity [1], while ... Both the albumin-bound and free fractions may ... testosterone action. Measurement of the free or ...
Medicine Products: